C. Unal Et Al. , "Survival results according to Oncotype Dx recurrence score in patients with hormone receptor positive HER-2 negative early-stage breast cancer: first multicenter Oncotype Dx recurrence score survival data of Turkey," FRONTIERS IN ONCOLOGY , vol.13, 2023
Unal, C. Et Al. 2023. Survival results according to Oncotype Dx recurrence score in patients with hormone receptor positive HER-2 negative early-stage breast cancer: first multicenter Oncotype Dx recurrence score survival data of Turkey. FRONTIERS IN ONCOLOGY , vol.13 .
Unal, C., Ozmen, T., Ordu, C., Pilanci, K. N., Ilgun, A. S., Gokmen, E., ... Almuradova, E.(2023). Survival results according to Oncotype Dx recurrence score in patients with hormone receptor positive HER-2 negative early-stage breast cancer: first multicenter Oncotype Dx recurrence score survival data of Turkey. FRONTIERS IN ONCOLOGY , vol.13.
Unal, Caglar Et Al. "Survival results according to Oncotype Dx recurrence score in patients with hormone receptor positive HER-2 negative early-stage breast cancer: first multicenter Oncotype Dx recurrence score survival data of Turkey," FRONTIERS IN ONCOLOGY , vol.13, 2023
Unal, Caglar Et Al. "Survival results according to Oncotype Dx recurrence score in patients with hormone receptor positive HER-2 negative early-stage breast cancer: first multicenter Oncotype Dx recurrence score survival data of Turkey." FRONTIERS IN ONCOLOGY , vol.13, 2023
Unal, C. Et Al. (2023) . "Survival results according to Oncotype Dx recurrence score in patients with hormone receptor positive HER-2 negative early-stage breast cancer: first multicenter Oncotype Dx recurrence score survival data of Turkey." FRONTIERS IN ONCOLOGY , vol.13.
@article{article, author={Caglar Unal Et Al. }, title={Survival results according to Oncotype Dx recurrence score in patients with hormone receptor positive HER-2 negative early-stage breast cancer: first multicenter Oncotype Dx recurrence score survival data of Turkey}, journal={FRONTIERS IN ONCOLOGY}, year=2023}